Trial reportLasers in medical science2026
Effectiveness of a novel low-level laser therapy protocol in managing breast cancer-related lymphedema.
Trial report in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we investigate the effects of low-level laser therapy (LLLT) at different wavelengths on lymphedema to further determine the appropriate protocol and effectiveness of LLLT in patients with breast cancer-related lymphedema (BCRL). A randomized controlled trial was conducted involving 46 patients with BCRL. Participants were assigned to receive 904 nm LLLT, 650 nm LLLT, or sham treatment. ICG lymphography was used to assess dermal backflow as a marker of lymphatic dysfunction. Ultrasonography was used to assess subcutaneous thickness and tissue mechanical properties; shear wave velocity (SWV), with higher values indicating greater tissue stiffness, was measured using shear wave elastography. Extracellular fluid volume and local tissue water content were evaluated using multifrequency bioelectrical impedance analysis (MFBIA) and tissue dielectric constant (TDC), respectively. No significant between-group differences were observed in ICG lymphography, MFBIA, or TDC outcomes. For ultrasonographic outcomes, the overall between-group difference in the change in upper-lateral SWV ratio was significant (p = 0.029), and Bonferroni-adjusted post-hoc analysis showed a greater reduction in Group A (904 nm) than in Group B (650 nm) (adjusted p = 0.026). Within Group A, SWV ratios decreased significantly at the lower-lateral site and at the LLLT treatment site. These site-specific findings were not accompanied by measurable changes in lymphatic transport or fluid-related outcomes. Adding 904 nm-650 nm LLLT to conventional decongestive therapy did not produce significant additional effects on extracellular fluid-related or lymphatic functional outcomes. Site-specific reductions in SWV observed with 904 nm LLLT suggest a potential wavelength-dependent effect on local tissue mechanical properties; however, these findings are limited and should be considered exploratory. Larger adequately powered studies with prespecified primary outcomes and longer follow-up are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.